Bluejay Diagnostics, Inc. (BJDX)
- Sector
- Healthcare
- Industry
- Medical Devices
- Last price
- $2.35
- As of
Kresmion compiles this page from BJDX's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Bluejay Diagnostics, Inc. (BJDX): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-11-04.
See the full BJDX dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for BJDX on one page. Preview it with sample data, then open it live with a free account.
Preview the BJDX dossierActive events for BJDX
- mediumEarnings below estimates
Q1-2023: Missed consensus by 96.1% - EPS $-3840 vs $-1958.4 estimate
- mediumEarnings below estimates
Q2-2023: Missed consensus by 79.7% - EPS $-4400 vs $-2448 estimate
- mediumEarnings below estimates
Q3-2023: Missed consensus by 150.2% - EPS $-3328 vs $-1330.08 estimate
- mediumEarnings below estimates
Q4-2023: Missed consensus by 166.2% - EPS $-2976 vs $-1117.92 estimate
- mediumEarnings below estimates
Missed consensus by 96.1% - EPS $-3840 vs $-1958.4 estimate
FREE, NO ACCOUNT
Every event on BJDX, as it fires
You are seeing 5 of 8 events recorded on BJDX since 2026-06-09.
The five above landed across 2 days. The other 3 were recorded on those same days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.
Recent SEC filings, BJDX
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Going concern statement
BJDX's 10-Q filed Aug 12, 2026 states:
These conditions raise substantial doubt about the Company's ability to continue as a going concern within one year from the date these financial statements are issued.
Read the 10-Q on SEC EDGAR Every company with a going concern statement
More data on BJDX
BJDX against its peers
BJDX's return on equity of -114.6% ranks in the 66th percentile of 15 Medical Devices sub-industry peers, fiscal periods ending between 2025-09-30 and 2026-06-30.
| Metric | BJDX | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | n/a | 3.0M | n/a | 18 |
| Revenue YoY | n/a | -26.8% | n/a | 6 |
| Gross margin | n/a | 59.8% | n/a | 15 |
| Operating margin | n/a | -134.3% | n/a | 15 |
| Net margin | n/a | -197.3% | n/a | 16 |
| Return on equity | -114.6% | -219.4% | 66 | 15 |
Peers (20): AIDX, IVF, RMSL, BDMD, CODX, XAIR, ICCM, VVOS, AMIX, NUWE, ADGM, VYCO, WOK, TNON, NXL, STME, NVNO, TANAF, USAQ, ESMC. Left out: CSDX (no annual filing), FZMD (period gap), PMEDF (period gap), TRIB (period gap), KLYG (no annual filing). Fiscal periods ending between 2025-09-30 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (BJDX: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in BJDX on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on BJDX in the last 180 days.
Upstream: SEC EDGAR filings for BJDX
Kresmion, "Bluejay Diagnostics, Inc. (BJDX) institutional holdings and SEC filings", data as of 2026-11-04, https://kresmion.com/research/BJDX. Upstream data: SEC EDGAR filings for BJDX.
Link to this data (HTML):
<a href="https://kresmion.com/research/BJDX">Bluejay Diagnostics, Inc. (BJDX) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow BJDX on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to BJDX for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.